DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Fulcrum Therapeutics Q4 EPS $(0.71) Beats $(0.83) Estimate

Fulcrum Therapeutics (NASDAQ:FULC) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.83) by 14.46 percent. This is a 90.92 percent increase over losses of $(7.82) per share

Benzinga · 03/05/2020 12:14

Fulcrum Therapeutics (NASDAQ:FULC) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.83) by 14.46 percent. This is a 90.92 percent increase over losses of $(7.82) per share from the same period last year.